{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-24-005476","form_type":"8-K","ticker":"PBSV","cik":"0001304161","company_name":"Pharma-Bio Serv, Inc.","filed_at":"2024-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.778234+00:00","generated_at":"2026-06-03T00:04:28.580560+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Stockholders approve extension of long-term incentive plan to 2034; re-elect two directors","bullets":["Stockholders approved extending the 2014 Long-Term Incentive Plan term to March 31, 2034.","Re-elected Kirk Michel (12.65M votes for) and Dov Perlysky (7.55M votes for) as Class II directors until 2027.","Crowe PR PSC ratified as independent auditor for fiscal year ending Oct 31, 2024 (14.36M for, 1.5K against)."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-24-005476","json":"https://secwatch.observer/filing/0001654954-24-005476.json","markdown":"https://secwatch.observer/filing/0001654954-24-005476.md","text":"https://secwatch.observer/filing/0001654954-24-005476.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1304161/000165495424005476/0001654954-24-005476-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1304161/000165495424005476/pbsv_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T00:04:28.580560+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"48e5bfb5e59e634f8d5310c749edd8ca38655a14","claim":"Pharma-Bio Serv, Inc. shareholders approved Approval of the Plan Amendment.","evidence_excerpt":"The approval of the Plan Amendment received the following votes: Votes For Votes Against Abstain 7,523,008 5,127,032 3,854,521 There were 1,714,854 broker non-votes on this proposal.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1304161/000165495424005476/0001654954-24-005476-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"},{"claim_id":"a76f2dd5ee10e3689c96468bc237c4ab384b1640","claim":"Pharma-Bio Serv, Inc. shareholders approved Election of Class II Directors.","evidence_excerpt":"Kirk Michel and Dov Perlysky received the following votes: Nominee Votes For Votes Withheld Kirk Michel 12,647,540 3,857,021 Dov Perlysky 7,546,374 8,958,187 There were 1,714,854 broker non-votes on this proposal.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1304161/000165495424005476/0001654954-24-005476-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"},{"claim_id":"f0286e71cafc8e0d15a12f3d9e93c06c7804549f","claim":"Pharma-Bio Serv, Inc. shareholders approved Ratification of Crowe PR PSC as independent certified public accountants at the 2024-10-31 meeting.","evidence_excerpt":"The ratification of the selection of Crowe PR PSC as the Company's independent certified public accountants for the fiscal year ending October 31, 2024 received the following votes: Votes For Votes Against Abstain 14,364,694 1,500 3,853,221 There were no broker non-votes on this proposal.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1304161/000165495424005476/0001654954-24-005476-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-10-31"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}